Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa
Opus Genetics, Inc. The trial is funded through Abu Dhabi’s Healthcare Research and Innovation Fund Clinical development activities will commence...
genetics
Opus Genetics starts MERTK RP gene therapy trial
Opus Genetics (Nasdaq: IRD) launched a clinical trial for OPGx-MERTK, an AAV-based gene therapy for...
Opus Genetics Launches Gene Therapy Clinical Trial for
The trial is funded through Abu Dhabi’s Healthcare Research and Innovation FundClinical development activities will commence at Cleveland Clinic Abu...
Opus Genetics reports positive pediatric data from LCA5 gene therapy study
Opus Genetics, Inc. released positive data from a pediatric cohort in an ongoing phase 1/2 clinical study evaluating OPGx-LCA5, an...
Opus Genetics Announces Presentation of OPGX-LCA5 Gene
Improvements in subjective and objective measures of efficacy observed at six months persisted for one year in patients with severe...
Opus Genetics reports 1-month pediatric results in gene therapy for inherited retinal disease
(Image Credit: AdobeStock/Artinun)Opus Genetics announced the 1-month open-label phase 1/2 results from the first pediatric patients treated with its investigational...
Opus Genetics Announces Presentations at Association for
Durham, NC., March 05, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene...
Doctoral Researcher in the Field of Genetics and Gene Therapy job with UNIVERSITY OF HELSINKI
We are looking for an excellent PhD Candidate to work in the field of genetics and gene therapy, in a HORIZON-EUROPE Consortium....
Department of Health – Abu Dhabi and Opus Genetics Announce Collaboration to Advance Ground-Breaking Gene Therapy Research for Inherited Retinal Diseases
ABU DHABI, UAE, June 4, 2024 /PRNewswire/ -- During the BIO 2024 International Convention, the Department of Health – Abu...
